Oakland, California (PRWEB) June 12, 2013
Steep Hill Laboratories, Inc. and Halent Scientific, the nation’s two leading cannabis testing and research companies, are pleased to announce they will be merging to form the leading analytical cannabinoid testing and research facility. The merger marks yet another leap forward in the nascent field of cannabis research, testing, and technological innovation, marrying Steep Hill’s innovation and technical prowess with Halent Scientific’s formidable research capabilities.
“We’ve worked hard to maintain a position of leadership for Steep Hill in the fields of cannabis testing and analytics,” said David Lampach, CEO and co-founder of Steep Hill Laboratories, Inc. “With this merger, we’ve achieved a new level of expertise and research ability that will ensure that Steep Hill-Halent will remain at the forefront of these fields and will also open up new avenues for providing clients with world class research, consulting, and testing methodology to further advance the industry.”
At a time when states like Washington, Colorado, and Massachusetts are mandating testing for their emerging cannabis markets, quality control is becoming paramount to ensuring consumer safety and establishing optimized regulatory frameworks. The newly merged Steep Hill-Halent is now an industry powerhouse in these areas.
“It is, indeed, exciting for us to now have an avenue for our research and methods to reach a much wider clientele,” said Donald Land, Ph.D., Chief Scientific Consultant and co-founder for Halent Scientific. “The combination of Steep Hill’s industry-leading volume and advanced analytics with Halent’s research and scientific acumen made this a very easy decision to combine forces to improve what were already world leading enterprises in the cannabis field.”
Since the release of Steep Hill Laboratory’s ground breaking QuantaCann, the first ever non-destructive marijuan
Copyright©2012 Vocus, Inc.
All rights reserved